Versa Vascular develops minimally invasive devices for the treatment of severe tricuspid regurgitation. Its technology aims to support native leaflet function and simplify intraprocedural imaging, serving patients with heart valve disorders.
Founded
1949
Total Funding
$10M+
Total Rounds
1
First Raise
Aug 11, 2026
Latest Raise
Aug 11, 2026
New funding rounds in your inbox every week 路 No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 8/11/2026 | |||
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week 路 Free